封面
市場調查報告書
商品編碼
1618150

透析市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

Dialysis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年,全球透析市場估值為921 億美元,預計2024 年至2032 年複合年成長率為5.5%。以及人口老化以及家庭透析解決方案的日益普及。透析設備的創新發展,例如攜帶式機器、家庭透析系統和更有效率的透析解決方案,改善了患者的治療效果並提供了更大的便利性。這些創新減少了治療時間並提高了靈活性,特別是在居家透析和穿戴式科技日益成長的趨勢下。這種轉變不僅提高了患者的生活品質,也有助於減輕醫療機構的壓力。

根據治療類型,市場分為血液透析和腹膜透析。 2023年,血液透析領域的收入為795億美元,使其成為領先的治療方式。血液透析對於治療晚期 CKD 和末期腎病 (ESRD) 至關重要,因為它可以過濾血液中的廢物和多餘液體。心血管疾病是腎臟損害的主要原因,它繼續導致血液透析需求不斷成長,隨著心臟病仍然普遍存在,預計需求將會增加。

就產品和服務而言,市場分為服務、消耗品和設備。 2023 年,服務領域佔據主導地位,佔 79% 的市場。透析中心的擴張,特別是在城市和城鄉結合部地區,增加了獲得重要治療的機會。主要透析提供者正在 CKD 高發生率地區投資建設更多設施,以支持住院和門診服務的成長。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 921 億美元
預測值 1,481 億美元
複合年成長率 5.5%

這種擴張是確保更多患者獲得一致照護的關鍵。北美在 2023 年以 318 億美元的收入引領市場,預計到 2032 年將以 5.4% 的複合年成長率成長。新的創新,例如更有效率的血液透析機、攜帶式腹膜透析系統和家用透析設備,提高了患者的舒適度並改善了臨床結果。這些發展正在增加先進透析解決方案的採用,從而改善整個北美地區獲得腎臟護理服務的機會。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 末期腎病 (ESRD) 患者數量不斷增加
      • 糖尿病發生率增加
      • 供腎短缺
      • 透析治療可獲得有利的報銷方案
      • 已開發國家和開發中國家的研發投資不斷增加
    • 產業陷阱與挑戰
      • 產品召回
      • 治療中的併發症
  • 成長潛力分析
  • 監管環境
  • 報銷場景
  • 技術景觀
  • 價值鏈分析
  • 波特的分析
  • PESTEL分析
  • 差距分析
  • 未來市場趨勢

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按類型,2021 - 2032

  • 主要趨勢
  • 血液透析
  • 腹膜透析

第 6 章:市場估計與預測:按產品和服務分類,2021 - 2032 年

  • 主要趨勢
  • 服務
    • 慢性透析
    • 急性透析
  • 耗材
    • 透析器
    • 導管
    • 接入產品
    • 濃縮物
    • 其他消耗品
  • 裝置
    • 透析機
    • 水處理系統
    • 其他設備

第 7 章:市場估計與預測:按最終用途,2021 - 2032 年

  • 主要趨勢
  • 中心透析
  • 居家透析

第 8 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 波蘭
    • 瑞典
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 印尼
    • 菲律賓
    • 馬來西亞
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 智利
    • 哥倫比亞
    • 秘魯
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 埃及
    • MEA 的其餘部分

第 9 章:公司簡介

  • AngioDynamics, Inc.
  • Asahi Kasei Corporation
  • B. Braun Holding GmbH & Co. KG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • DaVita Inc.
  • Dialife SA
  • Fresenius SE and Co. KGaA
  • JMS Co Ltd
  • KAWASUMI LABORATORIES INC
  • Medtronic Plc.
  • Nikkiso Co. Ltd.
  • Nipro Medical Corporation
  • Rogosin Institute
  • Satellite Healthcare
  • Teleflex Incorporated
  • Toray Industries Inc.
  • US Renal Care, Inc.
簡介目錄
Product Code: 3001

The Global Dialysis Market was valued at USD 92.1 billion in 2023 and is projected to grow at a CAGR of 5.5% from 2024 to 2032. This growth is driven by advancements in dialysis technologies, an increasing prevalence of chronic kidney disease (CKD), an aging population, and the rising adoption of home-based dialysis solutions. Innovative developments in dialysis equipment, such as portable machines, home dialysis systems, and more efficient dialysis solutions, improve patient outcomes and offer greater convenience. These innovations reduce treatment times and enhance flexibility, particularly with the growing trend toward home dialysis and wearable technologies. This shift not only improves patient quality of life but also helps reduce the strain on healthcare facilities.

The market is segmented into hemodialysis and peritoneal dialysis based on treatment type. In 2023, the hemodialysis segment accounted for USD 79.5 billion in revenue, making it the leading treatment modality. Hemodialysis is essential for managing advanced CKD and end-stage renal disease (ESRD), as it filters waste and excess fluids from the blood. Cardiovascular diseases, a leading cause of kidney damage, continue to contribute to the growing need for hemodialysis, with demand expected to rise as heart disease remains prevalent.

In terms of products and services, the market is categorized into services, consumables, and equipment. The services segment dominated in 2023, capturing 79% of the market share. The expansion of dialysis centers, especially in urban and semi-urban areas, has increased access to vital treatment. Major dialysis providers are investing in more facilities in regions with a high prevalence of CKD, supporting the growth of both in-hospital and outpatient services.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$92.1 Billion
Forecast Value$148.1 Billion
CAGR5.5%

This expansion is key to ensuring more patients receive consistent care. North America led the market with USD 31.8 billion in revenue in 2023 and is expected to grow at a 5.4% CAGR through 2032. The region benefits from continuous advancements in dialysis technologies and treatment options. New innovations, such as more efficient hemodialysis machines, portable peritoneal dialysis systems, and home dialysis devices, enhance patient comfort and improve clinical outcomes. These developments are increasing the adoption of advanced dialysis solutions, thus improving access to renal care services across North America.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
      • 3.2.1.2 Increasing incidence of diabetes
      • 3.2.1.3 Shortage of donor kidneys
      • 3.2.1.4 Favorable reimbursement scenario available for dialysis treatment
      • 3.2.1.5 Growing R&D investments in developed as well as developing countries
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Product recalls
      • 3.2.2.2 Complications in the treatment
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Reimbursement scenario
  • 3.6 Technology landscape
  • 3.7 Value chain analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Gap analysis
  • 3.11 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hemodialysis
  • 5.3 Peritoneal dialysis

Chapter 6 Market Estimates and Forecast, By Product and Services, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Services
    • 6.2.1 Chronic dialysis
    • 6.2.2 Acute dialysis
  • 6.3 Consumables
    • 6.3.1 Dialyzers
    • 6.3.2 Catheters
    • 6.3.3 Access products
    • 6.3.4 Concentrates
    • 6.3.5 Other consumables
  • 6.4 Equipment
    • 6.4.1 Dialysis machines
    • 6.4.2 Water treatment systems
    • 6.4.3 Other equipment

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 In-center dialysis
  • 7.3 Home dialysis

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Poland
    • 8.3.7 Sweden
    • 8.3.8 Netherlands
    • 8.3.9 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Indonesia
    • 8.4.7 Philippines
    • 8.4.8 Malaysia
    • 8.4.9 Rest of APAC
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Chile
    • 8.5.5 Colombia
    • 8.5.6 Peru
    • 8.5.7 Rest of LATAM
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Israel
    • 8.6.5 Turkey
    • 8.6.6 Egypt
    • 8.6.7 Rest of MEA

Chapter 9 Company Profiles

  • 9.1 AngioDynamics, Inc.
  • 9.2 Asahi Kasei Corporation
  • 9.3 B. Braun Holding GmbH & Co. KG
  • 9.4 Baxter International Inc.
  • 9.5 Becton, Dickinson and Company
  • 9.6 DaVita Inc.
  • 9.7 Dialife SA
  • 9.8 Fresenius SE and Co. KGaA
  • 9.9 JMS Co Ltd
  • 9.10 KAWASUMI LABORATORIES INC
  • 9.11 Medtronic Plc.
  • 9.12 Nikkiso Co. Ltd.
  • 9.13 Nipro Medical Corporation
  • 9.14 Rogosin Institute
  • 9.15 Satellite Healthcare
  • 9.16 Teleflex Incorporated
  • 9.17 Toray Industries Inc.
  • 9.18 U.S. Renal Care, Inc.